
Saturday, May 04, 2024 3:46:54 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ORIC News
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/04/2025 08:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/31/2025 08:30:00 PM
- ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/25/2025 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/20/2025 08:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/14/2025 08:02:17 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/07/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 09:34:22 PM
- ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones • GlobeNewswire Inc. • 02/25/2025 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/18/2025 09:20:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2025 09:10:07 PM
- ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates • GlobeNewswire Inc. • 02/18/2025 09:05:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/07/2025 09:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/27/2025 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:30:21 PM
- ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones • GlobeNewswire Inc. • 01/13/2025 01:05:00 PM
- ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 09:15:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/03/2025 09:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/25/2024 09:15:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 10:47:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:10:09 PM
- ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 07:17:21 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/04/2024 09:15:00 PM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM